Failure of cytarabine in varicella-zoster infections.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002644:Chickenpox / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004279:DNA, Viral / Q000037:antagonists & inhibitors; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy*; D014645:Herpesvirus 3, Human; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D010919:Placebos; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D004279:DNA, Viral; D007166:Immunosuppressive Agents; D010919:Placebos; D003561:Cytarabine